| OAB0402 | Integrase strand inhibitors (INSTI) related changes in BMI and risk of diabetes | Oral abstract session with live Q&A | Co-morbidities |
| OAB0403 | Vitamin D and calcium intake are associated with bone deficits among adolescents living with HIV in Zambia and Zimbabwe | Oral abstract session with live Q&A | Co-morbidities |
| OAB0404 | Effects of lifestyle modification and annual screening in the prevention of cardiovascular risk factors in South African women with HIV | Oral abstract session with live Q&A | Co-morbidities |
| OAB0405 | Re-evaluating risk: evaluating opioid-related harm associated with stimulant use in people with chronic pain living with and without HIV | Oral abstract session with live Q&A | Co-morbidities |
| OAB0405 | Re-evaluating risk: evaluating opioid-related harm associated with stimulant use in people with chronic pain living with and without HIV | Oral abstract session with live Q&A | Co-morbidities |
| OAC0102 | Australia’s progress towards ending HIV as a public health threat: trends in epidemiological metrics over 2004-2021 | Oral abstract session with live Q&A | Surveillance: Measuring the HIV epidemic |
| OAC0103 | Characterising HIV incidence among people who inject drugs engaged with harm-reduction programs in four provinces in South Africa | Oral abstract session with live Q&A | Epidemiology of HIV |
| OAC0104 | The effect of unplanned care interruptions on the mortality of adults resuming antiretroviral therapy in South Africa: a survival analysis | Oral abstract session with live Q&A | Epidemiology of HIV |
| OAC0105 | The impact of same-day and rapid ART initiation under the Universal Health Coverage program on HIV outcomes in Thailand | Oral abstract session with live Q&A | Cascades of HIV care and treatment |
| OAC0202 | COVID-19 vaccine effectiveness by HIV status and injection drug use history | Oral abstract session with live Q&A | Epidemiology of COVID-19 |